The cash flow of ResMed Inc. over the past 10 years
Chart ResMed Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2026 Open the chart →In fiscal 2026, the latest fiscal year on file, ResMed Inc.'s operating cash flow was $1.81B and its capital expenditures $156.28M, leaving free cash flow of $1.65B. Free cash flow was above zero in all 10 years shown. It ranged from $216.31M in fiscal 2022 to $1.66B in fiscal 2025. Capital expenditures were highest in fiscal 2026, at $156.28M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2026ended Jun 30, 2026 | $1.81B | $156.28M | $1.65B |
| 2025ended Jun 30, 2025 | $1.75B | $89.86M | $1.66B |
| 2024ended Jun 30, 2024 | $1.4B | $99.46M | $1.3B |
| 2023ended Jun 30, 2023 | $693.3M | $119.67M | $573.63M |
| 2022ended Jun 30, 2022 | $351.15M | $134.84M | $216.31M |
| 2021ended Jun 30, 2021 | $736.72M | $102.71M | $634.01M |
| 2020ended Jun 30, 2020 | $802.25M | $95.33M | $706.92M |
| 2019ended Jun 30, 2019 | $459.05M | $68.71M | $390.34M |
| 2018ended Jun 30, 2018 | $505.03M | $62.58M | $442.44M |
| 2017ended Jun 30, 2017 | $414.05M | $62.22M | $351.83M |
Fiscal years as ResMed Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ResMed Inc.
- The revenue of ResMed Inc.
- The profitability of ResMed Inc.
- The debt of ResMed Inc.
- The dividends of ResMed Inc.
- All of ResMed Inc.'s financials, charted
Companies of a similar size
- VGVENTURE GLOBAL, INC.
- KMBKIMBERLY-CLARK CORPORATION
- BIIBBIOGEN INC.
- WECWEC ENERGY GROUP, INC.
- CCICROWN CASTLE INC.
Not investment advice. This page shows what ResMed Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.